Mucofortin (Acetylcysteine)

Acetylcysteine, the active ingredient in Mucofortin, is a mucolytic presented as an oral formulation for oral use. It helps to thin thick respiratory secretions and is used in patients with bronchitis or cough associated with excessive mucus.

GNH USA supplies Mucofortin as a licensed, GDP‑compliant international pharmaceutical supplier serving hospitals, pharmacies and clinics worldwide.

Acetylcysteine is used to thin mucus in the respiratory tract, helping patients with conditions characterized by thick secretions.

- Acute bronchitis: reduces the viscosity of sputum, facilitating expectoration. - Chronic bronchitis: aids long‑term clearance of mucus and improves cough efficiency. - Cough with excessive mucus: eases discomfort by breaking down viscous secretions.

Acetylcysteine is generally well tolerated, but adverse reactions can occur.

Common Side Effects: - Nausea: mild to moderate stomach upset. - Vomiting: occasional emesis after oral intake. - Taste disturbance: a sulfur‑like aftertaste. - Abdominal discomfort: mild cramping or pain. - Headache: transient headache episodes. - Rash: mild skin erythema.

Serious or Rare Side Effects: - Anaphylaxis: severe allergic reaction requiring immediate medical attention. - Severe skin reactions: such as Stevens‑Johnson syndrome. - Bronchospasm: sudden tightening of airway muscles. - Hypotension: marked drop in blood pressure. - Hepatic dysfunction: abnormal liver enzyme elevations.

When using Acetylcysteine, consider the following safety measures.

- Pregnancy: consult a healthcare professional before use. - Breastfeeding: use with caution and under medical guidance. - Renal impairment: dose may need adjustment; monitor renal function. - Asthma: observe for possible bronchospasm. - Concomitant nitroglycerin: increased risk of hypotension. - Store below 25°C: keep in the original pack, protect from moisture.

Acetylcysteine can interact with other medicines; awareness helps prevent adverse outcomes.

Major Interactions (Avoid): - Nitroglycerin: may potentiate hypotensive effects. - Activated charcoal: can reduce acetylcysteine absorption.

Moderate Interactions (Monitor Closely): - Anticoagulants (e.g., warfarin): possible increased bleeding risk. - Antipsychotics (e.g., clozapine): may enhance side‑effect profile. - Other mucolytics: additive mucolytic effect may cause excess sputum production.